The potential of contemporary diagnostic imaging modalities for improving assessment of treatment response in patients with locally advanced cervical cancer
- Authors: Klimenko E.V1, Khalimon A.I1, Rubtsova N.A1, Leont’ev A.V1, Mukhtarulina S.V1, Mal’tsagova K.H.1, Rerberg A.G1, Novikova E.G1, Kaprin A.D1
-
Affiliations:
- P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Radiology Research Centre of Minzdrav of Russia
- Issue: No 1S (2020): Supplement
- Pages: 34-43
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248762
- DOI: https://doi.org/10.18565/aig.2020.1suppl.34-43
- ID: 248762
Cite item
Abstract
Full Text
About the authors
E. V Klimenko
P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Radiology Research Centre of Minzdrav of Russia
Email: elenasherbahina@mail.ru
A. I Khalimon
P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Radiology Research Centre of Minzdrav of Russia
Email: elenasherbahina@mail.ru
N. A Rubtsova
P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Radiology Research Centre of Minzdrav of Russia
A. V Leont’ev
P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Radiology Research Centre of Minzdrav of Russia
S. V Mukhtarulina
P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Radiology Research Centre of Minzdrav of Russia
Email: svmukhtarulina@yandex.ru
K. H.R Mal’tsagova
P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Radiology Research Centre of Minzdrav of Russia
A. G Rerberg
P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Radiology Research Centre of Minzdrav of Russia
E. G Novikova
P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Radiology Research Centre of Minzdrav of Russia
A. D Kaprin
P. Hertsen Moscow Oncology Research Institute - branch of the National Medical Radiology Research Centre of Minzdrav of Russia
References
- Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ Радиологии» Минздрава России, 2019. 255 с.
- Смирнов Ю.А., Богачева Т.М., Валеев Р.Г. Ультразвуковая диагностика в оценке местной распространенности рака шейки матки. Казанский медицинский журнал. 2012; 93(5): 735-8.
- Itoh N., Sawairi M., Hanabayashi T., Mori H., Yamawaki Y., Tam ay a T. Neoadjuvant intraarterial infusion chemotherapy with a combination of mitomycin-c, vincristine, and cisplatin for locally advanced cervical cancer: a preliminary report. Gynecol Oncol. 1992; 47(3): 391-4. doi: 10.1016/0090-8258(92)90146-a
- Рерберг А.Г., Каприн А.Д., Костин А.А., Новикова Е.Г., Волченко Н.Н., Чулкова О.В., Болотина Л.В., Мухтарулина С.В., Хохриков Т.Н., Сидоров Д.Ю., Геворкян А.Р. Неоадъювантная комбинированная химиотерапия местнораспространенного рака шейки матки. Онкология. Журнал имени П.А. Герцена. 2017; 6(6): 32-7. doi: 10.17116/onkolog20176632-37
- Scarabelli C., Zarrelli A., Gallo A., Visentin M.C. Multimodal treatment with neoadjuvant intraarterial chemotherapy and radical surgery in patients with stage iiib-iva cervical cancer. A preliminary study. Cancer. 1995; 76(6): 1019-26. doi: 10.1002/1097-0142(19950915)76:6<1019::aid-cncr2820760616>3.0.co;2-4
- Ishikawa H., Kikkawa F., Tamakoshi K., Matsuzawa K., Kawai M., Suganuma N., Tomoda Y. Distribution of platinum in human gynecologic tissues and lymph nodes after intravenous and intraarterial neoadjuvant chemotherapy. Anticancer Res. 1996; 16(6b): 3849-53. PMID: 9042269
- Fujiwaki R., Iida K., Ohnishi Y., Watanabe Y., Ryuko K., Takahashi K., Miyazaki K. Intra-arterial neoadjuvant chemotherapy followed by radical surgery and radiotherapy for stage iib cervical carcinoma. Anticancer res. 1997; 17(5b): 3751-5. PMID: 9427774
- Sugiyama T., Nishida T., Hasuo Y., Fujiyoshi K., Yakushiji M. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer. Gynecol Oncol. 1998; 69(2): 130-6. doi: 10.1006/gyno.1998.4976
- Вишневская Е.Е., Косенко Н.А. Отдаленные результаты комплексной терапии больных раком шейки матки с неблагоприятным прогнозом. Вопросы онкологии. 1999; 45(4): 420-3.
- Usuki N., Hirokawa K., Tashiro T., Saiwai S., Miyamoto T. Intraarterial chemotherapy for uterine cervical adenocarcinoma: evaluation of its efficacy as neoadjuvant therapy. Nihon Igaku Hoshasen Gakkai Zasshi. 1999; 59(12): 670-3. [Article in Japanese]. PMID: 10565169
- Therasse P., Eisenhauer E.A., Verweij J. RECIST revisited: a review of validation studies on tumour assessment.Eur J. Cancer. 2006; 8: 1031-9. doi: 10.1016/j. ejca.2006.01.026
- Halappa V.G., Corona-Villalobos C.P., Bonekamp S., Li Z., Reyes D.K., Cosgrove D., et al. Neuroendocrine Liver Metastasis Treated by Using Intraarterial Therapy: Volumetric Functional Imaging Biomarkers of Early Tumor Response and Survival. Radiology. 2013; 266(2): 502-513. https://doi. org/10.1148/radiol.12120495
- Sousa J.P.L.B.A., Bekhor D., Saito Filho C.F.S., Bretas E.A.S., D'lppolito G. Abdominal perfusion computed tomography: clinical applications, principles and Technique. Radiol Bras. 2012; 45: 39-45.
- Sugiyama T., Nishida T., Hasuo Y., Fujiyoshi K., Yakushiji M. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer. Gynecol Oncol. 1998; 69(2): 130-6. doi: 10.1006/gyno.1998.4976
- Kim S., Kamaya A., Willmann J.C.T. Perfusion of the Liver: Principles and Applications in Oncology. Radiology. 2014; 272(2): 322-44. doi: 10.1148/ radiol.14130091.
- Axel L. Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. Radiology. 1980; 137(3): 679-86. doi: 10.1148/radiology.137.3.7003648.
- Корниенко В.Н., Пронин Н.Н., Пьяных О.С., Фадеева Л.М. Исследование тканевой перфузии головного мозга методом компьютерной томографии. Медицинская визуализация. 2007; 2: 70-81.
- Miles K., Hay ball M., Dixon A. Functional images of hepatic perfusion obtained with dynamic CT. Radiology. 1993; 188(2): 405-11. doi: 10.1148/ radiology.188.2.8327686
- Долгушин М.Б., Пронин Н.Н., Корниенко В.Н., и др. КТ-перфузия в оценке эффективности лучевой терапии метастатического поражения головного мозга. Медицинская физика. 2008; 2(38): 40-52.
- Журавлева М., Шершевер А. С., Трофимова Т.Н. Возможности перфузионной КТ в оценке результатов комбинированного и комплексного лечения глиом головного мозга. Уральский медицинский журнал. 2012; 4 (96): 81-4.
- Аптаев Ч., Жолдыбай Ж.Ж., Жакенова Ж.К., Ахметова Г.С., Захырова Х. Перфузионная компьютерная томография в диагностике и оценке эффективности лечения рака желудка. Онкология и радиология Казахстана. 2018; 2(48). 41-4.
- Cuneo K. C., Chenevert T. L., Ben-Josef E. et al. A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Transl Oncol. 2014; 7(5): 644-649. doi: 10.1016/j.tranon.2014.07.005.
- Nakao A., Kasuya H., Sahin T.T., et al. A phase I. doseescalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer. Cancer Gene Therapy. 2011; 18: 167-75. doi: 10.1038/cgt.2010.65
- Shi buy a K., Tsushima Y., Horisoko E., Noda S.E., Taketomi-Takahashi A., Ohno T., Amanuma M., Endo K., Nakano T.J. Blood flow change quantification in cervical cancer before and during radiation therapy using perfusion CT. Radiat Res. 2011; 52(6): 804-11. Epub 2011 Sep 30.
- Liu J., Fan H., Qiu G.P., Int J. Vascular permeability determined using multislice spiral CT perfusion can predict response to chemoradiotherapy in patients with advanced cervical squamous cell carcinoma. Clin Pharmacol Ther. 2017; 55(7): 619-26. doi: 10.5414/CP202847.
- Li X.S., Fan H.X., Zhu H.X., Song Y.L., Zhou C.W. The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer. Eur Radiol. 2012; 22(3): 617-24. doi: 10.1007/ s00330-011-2280-6.
- Magne N., Chargari C., Vicenzi L., et al. New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET. Cancer Treat. Rev. 2008; 34(8): 671-81. doi: 10.1016/j.ctrv.2008.08.003.
- Grigsby P., Siegel B., Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J. Clin Oncol. 2001; 19(17): 3745-9. doi: 10.1200/JCO.2001.19.17.3745
- Wong T., Jones E., Coleman R., et al. Positron emission tomography with 2-deoxy-2- 18 [F]uoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. Mol. Imaging Bio. 2004; 6(1): 55-62. doi: 10.1006/gyno.1993.1268
- Chu Y., Zheng A., Wang F., et al. Diagnostic value of F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis. Nucl Med Commun. 2014; 35(2): 144-150. doi: 10.1097/MNM.0000000000000026.
- Brooks R., Rader J., Dehdashti F., et al. Surveillance FDG-PET detectionof asymptomatic recurrences in patients with cervical cancer. Gynecol Oncol. 2009; 112(1): 104-9. doi: 10.1016/j.ygyno.2008.08.028
- Scottish Intercollegiate Guidelines Network. Management of cervical cancer/ (SIGN guideline no 99). 2008.
- National Comprehensive Cancer Network (NCCN) guidelines for cervical cancer. 2017.
- Young H., Baum R., Cremerius U., et al. Measurement of clinical and subclinical tumour response using 18-Fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J. Cancer. 1999; 35(13): 1773-82. doi: 10.1016/s0959-8049(99)00229-4
- Wang X., Koch S. Positron emission tomography/computed tomography potential pitfalls and artifacts. Curr Probl Diagn Radiol. 2009; 38(4): 156-69. doi: 10.1067/j.cpradiol.2008.01.001.
- Amit A., Person O., Keidar Z. FDG PET/CT in monitoring response to treatment in gynecological malignancies. Curr Opin Obstet Gynecol. 2013; 25(1):17-22. http://dx.doi.org/10.1097/GCO.0b013e32835a7e96
- Young H., Baum R., Cremerius U., at all. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J. Cancer. 1999; 35(13): 1773-82. doi: 10.1016/s0959-8049(99)00229-4
- Wahl R.L., Jacene H., Kasamon Y., Lodge M.A. From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors. J. Nucl Med. 2009; 50 Suppl 1:122S-50S. doi: 10.2967/jnumed.108.057307.
- Schwarz J., Grigsby P., Dehdashti F., et al. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries. J. Nucl Med. 2009; 50(1): 64S-73S. doi: 10.2967/jnumed.108.057257.
- Grigsby P., Siegel B., Dehdashti F., et al. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J. Clin Oncol. 2004; 22(11): 2167-71. doi: 10.1200/JCO.2004.09.035
- Avril N., Sassen S., Schmalfeldt B., et al. Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. J. Clin Oncol. 2005; 23(30):7445-53. doi: 10.1200/JCO.2005.06.965
- Banks T.I., von Eyben R., Hristov D., Kidd E.A. Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response. Cancer Med. 2018; 7(8): 3642-51. doi: 10.1002/cam4.1632.